Placebo
1235-SR-202-AF
Phase 2 small_molecule completed
Quick answer
Placebo for Atrial Fibrillation is a Phase 2 program (small_molecule) at Advanz Pharma Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Advanz Pharma Limited
- Indication
- Atrial Fibrillation
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed